1. Home
2. RESEARCH
3. Projects & Grants
4. A new family of anticancer drugs: selective cleavage of DNA three-way junctions by CU(II) peptide helicates acting as nucleases

A new family of anticancer drugs: selective cleavage of DNA three-way junctions by CU(II) peptide helicates acting as nucleases

Funding agency: 

Fundación AECC - Ideas Semilla 2021

Ref.: 

IDEAS211154VÁZQ

Duration: 

2021-2023

Main researcher: 

Miguel Vázquez

Research group: 

Vázquez López / Vázquez Sentís